Melanoma immunotherapy updates in 2016: clinical trials, developments and new survival data
Jeffrey Weber, MD, PhD of the NYU Langone Medical Center, New York, NY, discusses his satellite symposium talk on updates in melanoma immunotherapy at the 2016 World Congress of Cancers of the Skin (W...
Author: VJOncology
Added: 09/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 27, 2016 Category: Cancer & Oncology Source Type: podcasts
How best to treat NRAS-mutated melanoma
Jean-Jacques Grob, MD of the Aix-Marseille University and APHM Hospital CHU Timone, Marseille, France, discusses treatments for melanoma patients with NRAS mutation at the 2016 World Congress on Cance...
Author: VJOncology
Added: 09/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 27, 2016 Category: Cancer & Oncology Source Type: podcasts
Why genetic testing for skin cancer is important
Ichiro Okamoto, MD of the Medical University of Vienna, Vienna, Austria discusses the importance of genetic testing for skin cancer. Prof. Okamoto explains, that genetic testing will become more impor...
Author: VJOncology
Added: 09/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 27, 2016 Category: Cancer & Oncology Source Type: podcasts
Using biomarkers to predict response to combination therapies in BRAF-mutant melanoma
Grant McArthur, MBBS, BMedSci, PhD, FRACP, of the Peter MacCallum Cancer Centre, Melbourne, Australia, discusses the two currently approved combination therapies used for treating BRAF-mutant melanoma...
Author: VJOncology
Added: 09/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 27, 2016 Category: Cancer & Oncology Source Type: podcasts
Mechanisms of resistance to checkpoint inhibitors in melanoma
Paolo Ascierto, MD of the National Tumor Institute Fondazione G. Pascale, Naples, Italy provides an overview of his talk on the mechanisms of resistance against checkpoint inhibitors in melanoma at th...
Author: VJOncology
Added: 09/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Tumor-infiltrating lymphocytes and survival in melanoma
Martin Mihm, Jr., MD of Brigham and Women's Hospital, Boston, MA gives an overview of his talk on open questions in the histopathology of cutaneous tumors in 2016, which was part of the session on ope...
Author: VJOncology
Added: 09/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Developments in the genetic testing of melanoma in clinical practice
Maria Concetta Fargnoli, MD of University of L'Aquila, L'Aquila, Italy, discusses genetic testing for skin cancer in clinical practice. First, Dr Fargnoli highlights the review of all the important me...
Author: VJOncology
Added: 09/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Highlights in the development of new therapies and novel drugs in treating melanoma
Jeffrey Weber, MD, PhD of the NYU Langone Medical Center, New York, NY, discusses his introductory plenary lecture on the revolution and evolution of immunotherapy in melanoma given at the 2016 World ...
Author: VJOncology
Added: 09/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 23, 2016 Category: Cancer & Oncology Source Type: podcasts
How can biomarkers help predict patient reponse in melanoma
Gerold Schuler, MD of University Hospital Erlangen, Erlangen, Germany discussed the field of biomarkers in melanoma at the 2016 World Congress on Cancers of the Skin (WCCS) and the Congress of the Eur...
Author: VJOncology
Added: 09/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 23, 2016 Category: Cancer & Oncology Source Type: podcasts
The use of mouse models in melanoma with brain metastases to test new therapies
Clemens Krepler, MD of the Wistar Institute, Philadelphia, PA, provides an insight into the research on brain metastases in melanoma. Prof. Krepler believes that there is a need for biomarkers here. H...
Author: VJOncology
Added: 09/23/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 23, 2016 Category: Cancer & Oncology Source Type: podcasts
Is Immunotherapy Safe for Older Melanoma Patients?
How do adverse events from immunotherapy compare in younger vs older patients? Dr Weber comments on the safety of checkpoint inhibitors for our older patients. (Source: Medscape Oncology)
Source: Medscape Oncology - September 22, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
News from ASCO 2016 for melanoma
Jean-Jacques Grob, MD of the Aix-Marseille University and APHM Hospital CHU Timone, Marseille, France, discusses the latest updates from ASCO 2016 for melanoma. First, he highlights on the news that s...
Author: VJOncology
Added: 09/21/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 21, 2016 Category: Cancer & Oncology Source Type: podcasts
The developments of genetic testing and personalized cancer vaccines for patients with skin cancer
Grant McArthur, MBBS, BMedSci, PhD, FRACP, of the Peter MacCallum Cancer Centre, Melbourne, Australia, discusses the ways genetic testing is being carried out to date. First of all, there are some ver...
Author: VJOncology
Added: 09/21/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 21, 2016 Category: Cancer & Oncology Source Type: podcasts
Use of confocal microscopy and multiphoton microscopy to conduct thorough examinations of skin tissues
Giovanni Pellacani, MD of the University of Modena and Reggio Emilia, Modena, Italy, discusses his talk on imaging techniques in melanoma presented at the 2016 World Congress on Cancers of the Skin (W...
Author: VJOncology
Added: 09/21/2016 (Source: Oncology Tube)
Source: Oncology Tube - September 21, 2016 Category: Cancer & Oncology Source Type: podcasts
